Related Experiment Video
Updated: Jun 25, 2025

07:12
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
7.7K
Complex Regional Pain Syndrome in Cancer Cases: Current Knowledge and Perspectives
Chanon Thanaboriboon1,2, Márcia C Matos Macêdo1,3, Jordi Perez1
1Cancer Pain Clinic, Departments of Anesthesiology and Supportive and Palliative Care, McGill University Health Center, Montreal, Quebec, Canada.
International Medical Case Reports Journal
|May 23, 2024
Summary
Complex regional pain syndrome (CRPS) in cancer patients presents unique challenges. Early diagnosis and tailored multidisciplinary management are crucial for improving quality of life in these complex cases.
Area of Science:
- Pain Medicine
- Oncology
- Neurology
Background:
- Complex regional pain syndrome (CRPS) is a debilitating condition often triggered by trauma, significantly impacting quality of life.
- CRPS in cancer patients exacerbates pain, with limited understanding of its specific circumstances and mechanisms.
- Cancer-related pain presents unique challenges, and the comorbidity with CRPS requires further investigation.
Observation:
- Two cancer patients with CRPS were presented: one with tumor nerve compression treated interventionally, and another with Zoster infection managed multidisciplinary.
- The first case of CRPS was linked to direct tumor nerve compression, successfully managed with an interventional pain procedure.
- The second CRPS case in an immunocompromised cancer patient was associated with Zoster infection, responding to multidisciplinary pain management.
Findings:
- CRPS in cancer patients can stem from direct tumor compression or secondary infections like Zoster.
- Interventional pain procedures and multidisciplinary pain management strategies show efficacy in managing CRPS in cancer patients.
- Literature review explored CRPS and cancer pain coexistence, suggesting potential pathophysiology mechanisms.
Implications:
- Comorbid CRPS complicates cancer pain diagnosis and treatment, negatively affecting patient outcomes.
- Further research is essential to understand the presentation and optimal management of coexisting CRPS and cancer pain.
- Elucidating the interplay between CRPS and cancer pain is critical for advancing patient care and therapeutic strategies.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Nociception
27.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.9K
Pain
474
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
474
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159

